Clarivate Plc reports developments in data, analytics and workflow software for academia and government, intellectual property, and life sciences and healthcare. Its news commonly covers earnings, subscription and recurring revenue trends, cash flow and leverage actions, and progress under its operating improvement initiatives.
Company updates also focus on AI-enabled research and decision-support products, including Web of Science Research Intelligence, Nexus Connect, Cortellis Regulatory Intelligence, Derwent-based patent analytics and other Clarivate data assets. Recurring announcements address institutional research intelligence, academic library workflows, regulatory intelligence for life sciences teams, intellectual property benchmarks and investor conference appearances.
Clarivate (NYSE:CLVT) has entered into a partnership with the University of Melbourne to provide comprehensive library solutions and services. The collaboration includes implementing Alma, Primo, Leganto, Rapido, and Library Open Workflows platforms to enhance library management systems and resource discovery.
The partnership aims to deliver a world-class library systems platform that integrates academic AI and linked data to improve teaching, learning, and research capabilities. The Alma platform, currently used by over 2,700 libraries worldwide, will help streamline operations and enhance data-driven decision-making at Australia's leading university.
Clarivate (NYSE:CLVT) has announced the beta launch of its AI-powered Regulatory Assistant within the Cortellis Regulatory Intelligence platform. The new tool, set for full release in September, aims to help regulatory professionals in biopharma, medtech, and research organizations navigate complex global requirements more efficiently.
The AI Assistant features include conversational AI with referenced answers, chat history functionality, and multilingual capabilities. The solution has been developed with input from industry partners, including Moderna, and builds on Clarivate's 30+ years of regulatory expertise and proven AI platform that powers other solutions like Web of Science.
Clarivate (NYSE:CLVT), a global provider of transformative intelligence, has announced its participation in the upcoming Oppenheimer 28th Annual Technology, Internet & Communications Virtual Conference. CEO Matti Shem Tov and CFO Jonathan Collins will present on August 13, 2025, at 12:25 PM ET.
The presentation will be accessible via live webcast, with replay options available on the company's investor relations website for 90 days following the event.
Clarivate (NYSE:CLVT) has appointed Maroun S. Mourad as President of its Intellectual Property segment, effective September 8, 2025. Mourad, who previously served as President of Claims Solutions at Verisk Analytics, succeeds Gordon Samson, who will retire at the end of 2025.
Mourad brings extensive experience in data analytics and software, having grown businesses across the U.S., U.K., Europe, and emerging markets since 1998. He holds a BA in political science and a JD from UC Berkeley. The appointment aligns with Clarivate's strategy to drive long-term predictable growth in its IP business, which provides IP data, software, and expertise for innovation management and IP asset protection.
Clarivate (NYSE:CLVT) reported Q2 2025 results with total revenues of $621.4 million, down from $650.3 million in Q2 2024 due to divestitures. The company showed positive trends with organic revenue growth of 0.5% and organic ACV growth of 1.3%. Notably, organic recurring revenue mix improved to 88%, up 800 basis points from year-end 2024.
Q2 2025 net loss was $72.0 million ($0.11 per share), improving from a $304.3 million loss in Q2 2024. Adjusted EBITDA reached $261.6 million. The company generated $287.5 million in operating cash flow and repurchased 11.5 million shares in Q2. Management reaffirmed its 2025 outlook, projecting revenues of $2.28B-$2.40B and adjusted EBITDA of $940M-$1.00B.
[ "Organic revenue growth of 0.5% and organic ACV growth of 1.3%", "Improved recurring revenue mix to 88%, up 800 basis points from 2024", "Net loss improved significantly to $72.0M from $304.3M in Q2 2024", "Generated strong operating cash flow of $287.5M in H1 2025", "Executed share repurchase of 23.2M shares at average price of $4.29" ]Clarivate (NYSE:CLVT) has released its 2025 G20 research and innovation scorecard, offering comprehensive insights into global research collaboration and impact. The enhanced scorecard now includes data from the Emerging Sources Citation Index (ESCI) and features new metrics focusing on open access and SDG-aligned research.
Key findings reveal that Mainland China leads G20 research output with 900,000 papers in 2024, triple its 2015 volume. The European Union has doubled its collaboration with China to 6.6%, while the UK has increased international collaboration from 55% to 70% over the past decade. The United States maintains 43% international collaboration, with China being its largest international partner.
The interactive scorecard, available on Clarivate.com, launches ahead of the G20 Summit in Johannesburg, incorporating OECD field-level breakdowns and enhanced visualization tools.Clarivate (NYSE:CLVT), a global provider of transformative intelligence, has scheduled its second quarter 2025 financial results announcement for July 30, 2025, before market opening.
The company will host a conference call and webcast at 9:00 AM Eastern Time on the same day. The earnings release and supplementary materials will be available on Clarivate's investor relations website. U.S. participants can join via 800-715-9871, while international participants can dial +1 646-307-1963 using conference ID 7007526.